Global Diabetes: Prevention & control - current and future – University of Copenhagen

Forward this page to a friend Resize Print kalender-ikon Bookmark and Share

Global Health > Open events > Archive 2014 > Global Diabetes: Preve...

Global Diabetes: Prevention & control - current and future

Join us for this open lecture with Professor of Epidemiology & Medicine, Emory University, USA, Venkat Narayan. 

Time and place

18 December, 14:30 - 15:30 followed by a 1-hour reception

University of Copenhagen, Centre for Health and Society campus, Øster Farimagsgade 5, building 2, room 2.30


Due to limited seat capacity, you need to sign up in order to participate by contacting Dirk L. Christensen no later than Sunday December 14.

Professor Venkat Narayan will cover different sub-topics relevant to diabetes and global health epidemiologists and clinicians.

Economic development and an explosion of diabetes  

Two major macro-level changes are currently sweeping the world: major economic development across low- and middle-income countries(LMICs), such as China, India, and others, and impressive improvements in life expectancies in almost all countries of the world.

Accompanying these trends are a shift in the global burden of disease, which is transitioning toward chronic non-communicable diseases (NCD) everywhere, while the unfinished agenda of infectious diseases and under-nutrition still exist in LMICs.  An example of this phenomenon is the explosion of diabetes worldwide, in low, middle, and high income countries, in urban and rural areas, and in rich and poor populations. Left unchecked the impact on human health and economics will be devastating.

Global science collaborations can enable diabetes prevention

Fortunately, current evidence exists that almost 50% of diabetes may be preventable and so too 50% of diabetes complications. But the problem is in implementation.  Using India as a case study, we argue that global collaboration between high-income countries and LMICs can not only advance the science of implementation to close the gap between knowledge and its application for human health everywhere, but also offer newer insights into the unique causes of diabetes in populations.

These points will be made using data from randomized controlled translation trials of prevention and treatment of diabetes in India that highlight the feasibility of implementation of aggressive programs. Preliminary results from epidemiological studies that clearly indicate unique aspects of the diabetes phenotype in Asian Indians (e.g., possible innate beta cell problems in either mass or function) will be shared. These data probably have implications for the majority of diabetes worldwide, and call for aggressive global collaboration and a two-prong approach - combining implementation research on the one the hand, and inter-disciplinary etiological/pathophysiological research on the other hand - to address the growing burden of type 2 diabetes globally, especially in LMICs.

Read more about:

Venkat Narayan, K.M. Venkat Narayan, MD, Ruth and O.C. Hubert Chair of Global Health, professor of medicine & epidemiology, Emory University, Atlanta